Reports Q2 revenue $504.58M, consensus $507.74M. “Our first year as a listed company is off to a great start. Demand for healthcare real estate is evident in our portfolio performance. Growth in the first half of 2024 is exceeding the expectations we set at the beginning of the year prompting our upward revisions to Same-Store NOI growth guidance and NFFO guidance. As we plan for the balance of the year and into 2025, we expect the elevated levels of Same-Store NOI growth to persist due to the demand-supply imbalance present in long-term care,” said Danny Prosky, the Company’s President and CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT (“AHR”) Announces Second Quarter 2024 Results; Increases Full Year 2024 Guidance
- AHR Earnings this Week: How Will it Perform?
- American Healthcare REIT price target raised to $17 from $16 at Truist
- Skilled nursing facilities’ outlook likely improved by Chevron ruling, says RBC
- American Healthcare REIT Announces Second-Quarter Distribution